Hepatitis C News and Research

Latest Hepatitis C News and Research

Parents do not perceive need to vaccinate children against influenza, study finds

Despite the fact that influenza leads to more hospitalizations and deaths among children than any other vaccine-preventable disease, parents frequently decline vaccinating their children against influenza because they don't perceive the need, according to a new case-control study published in the October issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology.

30 Sep 2016

MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

Hepatitis B (HBV) is a viral infection that increases the likelihood of developing liver cancer or liver failure.

26 Sep 2016

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis announced today that the US Food and Drug Administration has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes.

24 Sep 2016

Global study assesses countries on health-related Sustainable Development Goals

Worldwide, good progress has been made towards some of the health-related Sustainable Development Goals (SDGs) since 2000, particularly in reducing under-5 and neonatal mortality, family planning, and the rollout of universal health care.

24 Sep 2016

New global health strategy aims to eliminate HCV as global public health threat by 2030

Chronic infection by the hepatitis C virus (HCV) proved fatal for over 700,000 people worldwide in 2013, mainly as a result of liver damage. Although information on the epidemiology of transmission and infection is sparse, recent estimates put the global prevalence of HCV infection at 130-150 million people.

21 Sep 2016

Mice study finds new antiviral that can control flu infection

A molecule the body produces naturally in response to virus infection could be a viable flu treatment in the future, suggest researchers at the Francis Crick Institute in London.

20 Sep 2016

Tips to prevent back-to-school illnesses in children

The backpacks are packed, lunchboxes are filled and the little ones are back in school. Kids have returned to their classrooms with stories of their summer vacations, and, unfortunately, with a host of germs ready to spread quickly in a close environment.

20 Sep 2016

New study raises safety concerns on clinical use of caspase inhibitors for liver diseases

Many acute and chronic liver diseases, including alcoholic hepatitis, result from apoptotic (programmed) cell death mediated by the enzyme caspase. Caspase inhibitors have therapeutic potential to treat and prevent apoptosis-mediated liver injury, and some are currently in clinical trials.

9 Sep 2016

New vaccine against grass pollen allergies may help combat hepatitis B infection

A new type of vaccine against grass pollen allergies (BM32) might also offer an effective treatment for combating hepatitis B infection.

8 Sep 2016

Experts recommend removal of restrictions in accessing new hepatitis C therapies for drug users

Global health experts are today are calling for the removal of restrictions preventing people who use drugs from accessing new hepatitis C cures. So long as these restrictions exist, the goal of disease elimination will remain out of reach, they say.

7 Sep 2016

Hospitalizations for injection drug use-related infective endocarditis increasing among young Americans

Hospitalizations for infective endocarditis, a heart valve infection often attributed to injection drug use, have increased significantly among young adult Americans--particularly in whites and females--according to a new study by researchers from Tufts Medical Center and Tufts University School of Medicine.

1 Sep 2016

People with migraine feel isolated, stigmatized and often dissatisfied with treatment, survey reveals

Migraine in America 2016, a national survey by Health Union of more than 3,900 individuals experiencing migraines, reveals that patients have numerous treatment options, but are often dissatisfied with results.

31 Aug 2016

Pre-travel consultation can help international travelers to prepare for trip

International tourism exceeds 1.2 billion persons each year, with more than 20 percent of travelers reporting some type of illness.

31 Aug 2016

Study shows many older jail inmates experience health-related distressing symptoms

More than 550,000 adults 55-years-old and older are arrested and detained every year--and that number is increasing rapidly.

29 Aug 2016

Liver cancer time-bomb as up to 70% people with Hep C miss out on follow-up testing

Up to 70 per cent of Victorians with suspected hepatitis C may not have received follow-up testing, putting them at risk of chronic liver disease and even cancer, University of Melbourne researchers say.

26 Aug 2016

HIV-infected adults with MDD more likely to experience heart attack, study shows

Among more than 26,000 human immunodeficiency virus (HIV)-infected adults, those with major depressive disorder (MDD) were more likely to experience a heart attack than those without MDD, according to a study published online by JAMA Cardiology.

24 Aug 2016

New method estimates patient adherence to antiretroviral drugs

Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at CU Anschutz have developed a technique that estimates an HIVnegative patient's adherence to drugs prescribed to prevent HIV transmission during sex.

24 Aug 2016

Low selenium levels linked to liver cancer risk? An interview with Dr David Hughes

Food provides us with a variety of substances we need to maintain life. These substances are essential nutrients and are classified as macronutrients (water, protein, fats, and carbohydrates) and micronutrients (vitamins and minerals).

22 Aug 2016

Researchers urge people with suspected hepatitis C to get tested to prevent risk of liver disease

17 Aug 2016

Penicillin allergy testing: an interview with Dr. Eric Macy

Penicillin was one of the first antibiotics developed and has saved millions of lives. First used in the early 1940s, penicillin is still one of the most widely used and least toxic family of antibiotics.

17 Aug 2016

Hepatitis C News and Research

Latest Hepatitis C News and Research

Parents do not perceive need to vaccinate children against influenza, study finds

MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Global study assesses countries on health-related Sustainable Development Goals

New global health strategy aims to eliminate HCV as global public health threat by 2030

Mice study finds new antiviral that can control flu infection

Tips to prevent back-to-school illnesses in children

New study raises safety concerns on clinical use of caspase inhibitors for liver diseases

New vaccine against grass pollen allergies may help combat hepatitis B infection

Experts recommend removal of restrictions in accessing new hepatitis C therapies for drug users

Hospitalizations for injection drug use-related infective endocarditis increasing among young Americans

People with migraine feel isolated, stigmatized and often dissatisfied with treatment, survey reveals

Pre-travel consultation can help international travelers to prepare for trip

Study shows many older jail inmates experience health-related distressing symptoms

Liver cancer time-bomb as up to 70% people with Hep C miss out on follow-up testing

HIV-infected adults with MDD more likely to experience heart attack, study shows

New method estimates patient adherence to antiretroviral drugs

Low selenium levels linked to liver cancer risk? An interview with Dr David Hughes

Researchers urge people with suspected hepatitis C to get tested to prevent risk of liver disease

Penicillin allergy testing: an interview with Dr. Eric Macy

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Hepatitis C News and Research

Latest Hepatitis C News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in